News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
276,895 Results
Type
Article (17403)
Company Profile (36)
Press Release (259454)
Multimedia
Podcasts (22)
Webinars (5)
Section
Business (81587)
Career Advice (583)
Deals (14417)
Drug Delivery (30)
Drug Development (34269)
Employer Resources (40)
FDA (6205)
Job Trends (6271)
News (135322)
Policy (10301)
Tag
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (753)
Accelerated approval (14)
Adcomms (6)
Allergies (66)
Alliances (14501)
ALS (75)
Alzheimer's disease (627)
Antibody-drug conjugate (ADC) (149)
Approvals (6491)
Artificial intelligence (245)
Autoimmune disease (72)
Automation (17)
Bankruptcy (116)
Best Places to Work (4789)
BIOSECURE Act (2)
Biosimilars (101)
Biotechnology (24)
Bladder cancer (109)
Brain cancer (35)
Breast cancer (396)
Cancer (2650)
Cardiovascular disease (226)
Career advice (481)
Career pathing (8)
CAR-T (117)
CDC (5)
Celiac Disease (1)
Cell therapy (343)
Cervical cancer (22)
Clinical research (31431)
Collaboration (831)
Company closure (2)
Compensation (553)
Complete response letters (14)
COVID-19 (945)
CRISPR (46)
C-suite (386)
Cystic fibrosis (68)
Data (3642)
Decentralized trials (1)
Denatured (5)
Depression (55)
Diabetes (228)
Diagnostics (2359)
Digital health (20)
Diversity (3)
Diversity, equity & inclusion (11)
Drug discovery (115)
Drug pricing (74)
Drug shortages (9)
Duchenne muscular dystrophy (109)
Earnings (51374)
Editorial (16)
Employer branding (7)
Employer resources (35)
Events (45559)
Executive appointments (491)
FDA (7921)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (12)
Funding (744)
Gene editing (94)
Generative AI (16)
Gene therapy (276)
GLP-1 (497)
Government (1384)
Grass and pollen (5)
Guidances (347)
Healthcare (6639)
HIV (31)
Huntington's disease (17)
IgA nephropathy (51)
Immunology and inflammation (109)
Immuno-oncology (23)
Indications (51)
Infectious disease (1077)
Inflammatory bowel disease (82)
Inflation Reduction Act (9)
Influenza (53)
Intellectual property (96)
Interviews (112)
IPO (8027)
IRA (16)
Job creations (1761)
Job search strategy (411)
JPM (24)
Kidney cancer (7)
Labor market (36)
Layoffs (194)
Leadership (5)
Legal (2181)
Liver cancer (45)
Longevity (3)
Lung cancer (391)
Lymphoma (216)
Machine learning (19)
Management (12)
Manufacturing (324)
MASH (88)
Medical device (4900)
Medtech (4922)
Mergers & acquisitions (6947)
Metabolic disorders (589)
Multiple sclerosis (91)
NASH (10)
Neurodegenerative disease (146)
Neuropsychiatric disorders (43)
Neuroscience (1235)
Neurotech (1)
NextGen: Class of 2026 (2376)
Non-profit (1595)
Now hiring (13)
Obesity (265)
Opinion (75)
Ovarian cancer (84)
Pain (81)
Pancreatic cancer (99)
Parkinson's disease (140)
Partnered (12)
Patents (170)
Patient recruitment (210)
Peanut (22)
People (16624)
Pharmaceutical (8)
Pharmacy benefit managers (10)
Phase 1 (8671)
Phase 2 (13769)
Phase 3 (11696)
Pipeline (3277)
Policy (68)
Postmarket research (1071)
Preclinical (2927)
Press Release (44)
Prostate cancer (135)
Psychedelics (12)
Radiopharmaceuticals (97)
Rare diseases (391)
Real estate (2137)
Recruiting (14)
Regulatory (8611)
Reports (21)
Research institute (701)
Resumes & cover letters (117)
Rett syndrome (25)
RNA editing (7)
RSV (41)
Schizophrenia (71)
Series A (104)
Series B (95)
Service/supplier (5)
Sickle cell disease (44)
Special edition (10)
Spinal muscular atrophy (69)
Sponsored (14)
Startups (1243)
Stomach cancer (3)
Supply chain (50)
Tariffs (33)
The Weekly (17)
Vaccines (397)
Venture capital (31)
Weight loss (195)
Women's health (34)
Worklife (3)
Date
Today (35)
Last 7 days (225)
Last 30 days (1286)
Last 365 days (16623)
2026 (1296)
2025 (16822)
2024 (15103)
2023 (15017)
2022 (18874)
2021 (20133)
2020 (17970)
2019 (15532)
2018 (11807)
2017 (10742)
2016 (11550)
2015 (44339)
2014 (19409)
2013 (5929)
2012 (6496)
2011 (7322)
2010 (6287)
Location
Africa (372)
Alabama (27)
Alaska (3)
Arizona (83)
Arkansas (3)
Asia (16873)
Australia (2720)
California (6081)
Canada (1573)
China (516)
Colorado (244)
Connecticut (293)
Delaware (232)
Europe (40976)
Florida (713)
Georgia (157)
Hawaii (3)
Idaho (20)
Illinois (481)
India (32)
Indiana (302)
Iowa (10)
Japan (275)
Kansas (44)
Kentucky (15)
Louisiana (15)
Maine (35)
Maryland (636)
Massachusetts (4420)
Michigan (189)
Minnesota (273)
Mississippi (3)
Missouri (86)
Montana (11)
Nebraska (6)
Nevada (74)
New Hampshire (28)
New Jersey (1817)
New Mexico (6)
New York (1454)
North Carolina (657)
North Dakota (3)
Northern California (2978)
Ohio (146)
Oklahoma (7)
Oregon (15)
Pennsylvania (1015)
Puerto Rico (5)
Rhode Island (10)
South America (472)
South Carolina (13)
Southern California (2329)
Tennessee (104)
Texas (952)
United States (20888)
Utah (163)
Virginia (130)
Washington D.C. (31)
Washington State (493)
West Virginia (3)
Wisconsin (88)
276,895 Results for "15".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Collaboration
Kite Makes $1.5B+ Cell Therapy Pact With Pregene as Others Pull Back
With more than $1.5 billion on the line, Gilead looks to bolster its CAR T portfolio.
October 17, 2025
·
2 min read
·
Tristan Manalac
Press Releases
MIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX®
February 2, 2026
·
1 min read
China
AstraZeneca Pledges $15B More in Chinese Investments for Cell Therapies, Radiopharma
AstraZeneca has risen as one of pharma’s most prolific investors in China, including a $630 million pledge last week for full rights to AbelZeta’s cell therapy for cancer.
January 29, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering
January 15, 2026
·
5 min read
Press Releases
Avant Technologies Evaluating Advanced Cells for Diabetes Therapy at 15th Annual EPITA Symposium
January 27, 2026
·
3 min read
Press Releases
BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA
January 9, 2026
·
1 min read
Alzheimer’s disease
Novartis Makes $1.5B+ Alzheimer’s Play With China’s SciNeuro
The deal will see Novartis gain global rights over SciNeuro’s potentially disease-modifying anti-amyloid antibody, which leverages the latter’s proprietary shuttle platform to allow delivery into the brain.
January 12, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Aytu BioPharma to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026
January 14, 2026
·
1 min read
Press Releases
Dentsply Sirona Declares Quarterly Cash Dividend - December 15, 2025
December 16, 2025
·
1 min read
Mergers & acquisitions
Sobi Makes $1.5B Gout Play With Arthrosi Acquisition
For $950 million upfront, Sobi will gain ownership to pozdeutinurad, an oral URAT1 inhibitor that performed well in Phase II studies.
December 15, 2025
·
2 min read
·
Tristan Manalac
1 of 27,690
Next
